240 related articles for article (PubMed ID: 7522267)
1. CSF concentration gradients of monoamine metabolites in patients with hydrocephalus.
Malm J; Kristensen B; Ekstedt J; Wester P
J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1026-33. PubMed ID: 7522267
[TBL] [Abstract][Full Text] [Related]
2. Monoamine metabolites in ventricular CSF of children with posterior fossa tumors: correlation with tumor histology and cognitive functioning.
Varela M; Alexiou GA; Liakopoulou M; Papakonstantinou E; Pitsouni D; Alevizopoulos GA
J Neurosurg Pediatr; 2014 Apr; 13(4):375-9. PubMed ID: 24559277
[TBL] [Abstract][Full Text] [Related]
3. Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid.
Blennow K; Wallin A; Gottfries CG; Månsson JE; Svennerholm L
J Neural Transm Park Dis Dement Sect; 1993; 5(1):5-15. PubMed ID: 7679905
[TBL] [Abstract][Full Text] [Related]
4. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
Hjärpe J; Söderman E; Andreou D; Sedvall GC; Agartz I; Jönsson EG
Psychiatry Res; 2018 May; 263():30-34. PubMed ID: 29482043
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome.
Eriksson E; Alling C; Andersch B; Andersson K; Berggren U
Neuropsychopharmacology; 1994 Nov; 11(3):201-13. PubMed ID: 7532413
[TBL] [Abstract][Full Text] [Related]
6. Sampling issues of cerebrospinal fluid and plasma monoamines: Investigation of the circadian rhythm and rostrocaudal concentration gradient.
Janssens J; Atmosoerodjo SD; Vermeiren Y; Absalom AR; den Daas I; De Deyn PP
Neurochem Int; 2019 Sep; 128():154-162. PubMed ID: 31034914
[TBL] [Abstract][Full Text] [Related]
7. Increased concentrations of the monoamine metabolites homovanillic acid and 5-hydroxyindoleacetic acid in lumbar and central CSF and of 3-methoxy-4-hydroxyphenylglycol in lumbar CSF after subarachnoid haemorrhage.
von Holst H; Lindquist C; Sedvall G
Acta Neurochir (Wien); 1985; 77(3-4):146-51. PubMed ID: 2416192
[TBL] [Abstract][Full Text] [Related]
8. Concentration gradients of monoamine metabolites in human cerebrospinal fluid.
Sjöström R; Ekstedt J; Anggård E
J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):666-8. PubMed ID: 1159438
[TBL] [Abstract][Full Text] [Related]
9. CSF-amine metabolites in depression, dementia and in controls.
Gjerris A; Werdelin L; Gjerris F; Sørensen PS; Rafaelsen OJ; Alling C
Acta Psychiatr Scand; 1987 Jun; 75(6):619-28. PubMed ID: 2441573
[TBL] [Abstract][Full Text] [Related]
10. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
Yoshino K
No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
[TBL] [Abstract][Full Text] [Related]
11. Monoamine metabolites in cerebrospinal fluid during acute cerebral ischemia.
Tang HZ; Lu XF; Wang KJ; Ou YS; Huang YQ
Chin Med J (Engl); 1989 Jan; 102(1):18-23. PubMed ID: 2475306
[TBL] [Abstract][Full Text] [Related]
12. Monoamine metabolites in cerebrospinal fluid during and after acute cerebral ischemia.
Tang HZ; Lu XF; Wang KJ; Ouyang S; Huang YQ
Mol Chem Neuropathol; 1989 Apr; 10(2):77-85. PubMed ID: 2472800
[TBL] [Abstract][Full Text] [Related]
13. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers.
De Bellis MD; Geracioti TD; Altemus M; Kling MA
Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):636-41. PubMed ID: 7687151
[TBL] [Abstract][Full Text] [Related]
15. Concentration gradient of CSF monoamine metabolites in children and adolescents.
Kruesi MJ; Swedo SE; Hamburger SD; Potter WZ; Rapoport JL
Biol Psychiatry; 1988 Sep; 24(5):507-14. PubMed ID: 2458775
[TBL] [Abstract][Full Text] [Related]
16. Spinal reflexes and the concentrations of 5-HIAA, MHPG, and HVA in lumbar cereborspinal fluid after spinal lesions in man.
Ashby P; Verrier M; Warsh JJ; Price KS
J Neurol Neurosurg Psychiatry; 1976 Dec; 39(12):1191-200. PubMed ID: 1011029
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid monoamine metabolite concentrations as intermediate phenotypes between glutamate-related genes and psychosis.
Andreou D; Söderman E; Axelsson T; Sedvall GC; Terenius L; Agartz I; Jönsson EG
Psychiatry Res; 2015 Sep; 229(1-2):497-504. PubMed ID: 26142836
[TBL] [Abstract][Full Text] [Related]
18. Stability of monoamine metabolites in human cerebrospinal fluid.
Langlais PJ; Bird ED; McEntee WJ
Ann Neurol; 1982 Jul; 12(1):48-51. PubMed ID: 6180677
[TBL] [Abstract][Full Text] [Related]
19. Analysis of equine cisterna magna cerebrospinal fluid for the presence of some monoamine neurotransmitters and transmitter metabolites.
Vaughn DM; Smyth GB; Whitmer WL; Satjawatcharaphong C
Vet Res Commun; 1989; 13(3):237-49. PubMed ID: 2476887
[TBL] [Abstract][Full Text] [Related]
20. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
